Management of Non-Cystic Fibrosis Bronchiectasis.

CONSULTANT PHARMACIST Pub Date : 2018-11-01 DOI:10.4140/TCP.n.2018.658.

Stacey K Dull, Brooke D Havlat, Michael J Sanley, Mark A Malesker

{"title":"Management of Non-Cystic Fibrosis Bronchiectasis.","authors":"Stacey K Dull, Brooke D Havlat, Michael J Sanley, Mark A Malesker","doi":"10.4140/TCP.n.2018.658.","DOIUrl":null,"url":null,"abstract":"OBJECTIVE: The purpose of this report is to describe the case of a 43-year-old male with asthma who was hospitalized for an exacerbation of non-cystic fibrosis bronchiectasis (NCFB), a chronic lung disease that is characterized by dilation of the airways, persistent cough, chronic sputum production, and recurrent respiratory infections. He was treated with oral and inhaled antibiotics, inhaled bronchodilators, and aggressive airway-clearance techniques including nebulized 7% sodium chloride, flutter valve, and high-frequency chest wall oscillation. SETTINGS: Community pharmacy, nursing facility pharmacy, consultant pharmacy practice. PRACTICE CONSIDERATIONS: As the number of patients diagnosed with NCFB continues to increase, it is crucial to recognize that specific guidance for management of NCFB is warranted, as treatment responses differ from cystic fibrosis bronchiectasis or chronic obstructive pulmonary disease. CONCLUSION: It is important for pharmacists to understand the pharmacologic and nonpharmacologic treatments for NCFB to better assist physicians and patients and improve therapeutic outcomes.","PeriodicalId":45985,"journal":{"name":"CONSULTANT PHARMACIST","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2018-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"CONSULTANT PHARMACIST","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4140/TCP.n.2018.658.","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

Abstract

OBJECTIVE: The purpose of this report is to describe the case of a 43-year-old male with asthma who was hospitalized for an exacerbation of non-cystic fibrosis bronchiectasis (NCFB), a chronic lung disease that is characterized by dilation of the airways, persistent cough, chronic sputum production, and recurrent respiratory infections. He was treated with oral and inhaled antibiotics, inhaled bronchodilators, and aggressive airway-clearance techniques including nebulized 7% sodium chloride, flutter valve, and high-frequency chest wall oscillation. SETTINGS: Community pharmacy, nursing facility pharmacy, consultant pharmacy practice. PRACTICE CONSIDERATIONS: As the number of patients diagnosed with NCFB continues to increase, it is crucial to recognize that specific guidance for management of NCFB is warranted, as treatment responses differ from cystic fibrosis bronchiectasis or chronic obstructive pulmonary disease. CONCLUSION: It is important for pharmacists to understand the pharmacologic and nonpharmacologic treatments for NCFB to better assist physicians and patients and improve therapeutic outcomes.

查看原文本刊更多论文

非囊性纤维化支气管扩张症的治疗。

目的:本报告的目的是描述一名43岁男性哮喘患者因非囊性纤维化支气管扩张(NCFB)加重而住院的病例，NCFB是一种慢性肺部疾病，其特征是气道扩张、持续咳嗽、慢性产痰和反复呼吸道感染。他接受了口服和吸入抗生素、吸入支气管扩张剂和积极的气道清除技术的治疗，包括雾化7%氯化钠、颤振阀和高频胸壁振荡。设置:社区药房，护理机构药房，咨询药房实践。实践注意事项:随着诊断为NCFB的患者数量不断增加，认识到NCFB治疗的具体指导是必要的，因为治疗反应与囊性纤维化支气管扩张或慢性阻塞性肺疾病不同。结论:药师了解NCFB的药物和非药物治疗方法对更好地辅助医患，提高治疗效果具有重要意义。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

CONSULTANT PHARMACIST PHARMACOLOGY & PHARMACY-

自引率

0.00%

发文量

期刊介绍： Vision ... The Society"s long-term desire, aspiration, and core purpose. The vision of the American Society of Consultant Pharmacists is optimal medication management and improved health outcomes for all older persons. Mission ... The Society"s strategic position, focus, and reason for being. The American Society of Consultant Pharmacists empowers pharmacists to enhance quality of care for all older persons through the appropriate use of medication and the promotion of healthy aging.